Abstract:OBJECTIVE:To study the prokaryotic expression of extracellular ligand binding domains of chick tie-2, the purification, refolding conditions of the recombinant protein, and its anti-angiogeneic effect.METHODS:A DNA fragment encoding extracellular ligand binding domains of chick tie-2 was obtained by PCR amplification using a previous constructed plasmid as a template. The amplified fragment was then inserted into prokaryotic expression vector pQE30, and was expressed in E.Coli XL-1 blue by adding isopropyl-beta-D-thiogalactoside(IPTG). The recombinant protein in inclusion bodies was purified by nickel-nitrilotriacetic acid (Ni-NTA) affinity chromatography under denatured conditions. Then the refolding of the purified protein was performed with gradient dialysis. The target protein was injected s.c. into mouse, and the antibody was detected by ELISA and Western blot analysis. The antibody was purified from the antiserum and then incubated with human umbilical endothelial vein cell (HUEVC) to find its anti-angiogenesis in vitro by using propidium iodide(PI) dying through FACS. Alginate encapsulated tumor cell assays were performed and micro-vessel density was determined by counting per high power field in the sections stained with an antibody reactive to CD31 to test its inhibition of angiogenesis.RESULTS:The recombinant protein was highly expressed in E.Coli XL-1 blue, and the antibody produced in mouse could specifically recognize the recombinant protein. The purified antibody could induce apoptosis of HUEVC in vitro. The anti-angiogenic effect of the antibody could also be found in alginate-encapsulate tumor cell assay and by counting micro-vessel density.CONCLUSION:The protein of extracellular ligand binding domains of chick tie-2 can be expressed at high level in the prokaryotic expression system, and the expressed protein can induce immune response in mouse. Furthermore, the antibody can induce the anti-angiogenic effect.

PREPARATION OF RECOMBINANT PROTEIN OF EXTRACELLULAR LIGAND BINDING DOMAINS OF MOUSE VEGF RECEPTOR 2 AND ITS APPLICATION

Expression and Function Identification of Extracellular Domain 3 of Human Vascular Endothelial Growth Factor Receptor KDR

[Prokaryotic Expression, Purification and Identification of Recombinant Xenopus Laevis and Mouse Vascular Endothelial Growth Factors].

Cloning of cDNA Encoding Extra-Cellular Domain of Human VEGF Receptor KDR and Effect of Its Recombinant Protein on Endothelial Cell Proliferation and Angiogenesis

Prokaryotic Expression of VEGF165 and Preliminary Screening of Anti-VEGF Hybridoma Cell Lines

Immunotherapy effect on tumor and recombination of VGFR phage vaccine

Gene Synthesis,Protein Expression and Identification of VEGF189

AN ANTI-TUMOR RESEARCH OF RECOMBINANT PHAGE VACCINE EXPRESSED XENOGENIC EGFR

Preparation of extracellular domain 3 of human VEGF receptor-2 and the monitoring of its real-time binding to VEGF by biosensors.

[Prokaryotic Expression of Extracellular Ligand Binding Domains of Chick Tie-2 and Its Anti-Angiogenesis Effect].

Preparation and characterization of human anti-EGFR scFv-protamine fusion protein

Gene Cloning of Soluble VEGF Receptor FLT-1 and the Effect of Its Recombinant Protein on Angiogenesis

Prokaryotic Expression of Extracellular Domain of Human EGFR and It's Immunogenity

Prokaryotic Expression, Purification and Activity Assay of Recombinant Vascular Endothelial Growth Factor.

Screening the antigen epitopes of bFGF/VEGF and expressing and identifying their complex peptide

Construction,Expression and Biological Activity Studies of a Bivalent Single Chain Variable Fragment (BsFv)against Vascular Endothelial Growth Factor Receptor 2

A Promising New Approach of VEGFR2-based DNA Vaccine for Tumor Immunotherapy.

The construction of a DNAvaccine targeting extracellular region of PDGF-R-2β gene

Expression of human vascular endothelial growth factor receptor Flt-1 extracellular domain 1-3 loop cDNA in Pichia pastoris, purification of the expressed product and detection of its biological activity.

The Construction of Anti-EGFR Single Chain Variable Fragment Fused with Gelonin Toxin Prokaryotic Expressing Plasmid and the Study of Its Anti-tumor Effects

Expression and purification of human vascular-endothelial-growth-factor-receptor-2 tyrosine kinase in Streptomyces for inhibitor screening.